Skip to content
  • Join Us
  • Members Area
ASOI
  • Home
  • ASOI News
  • About Us
  • Events
  • Media Resources
  • Public Resources
  • Guidelines
  • Research

Publication Category: Medications

Obesity drug shortages are symptomatic of wider malaise

  • Sumithran P, Finucane FM, Cohen RV. Obesity drug shortages are symptomatic of wider malaise Lancet

Weight Management with Orlistat in Type 2 Diabetes – An Electronic Healthcare Records Study

  • Ghosal S, Heron N, Mason K, Bailey J, Jordan K. Weight Management with Orlistat in Type 2 Diabetes – An Electronic Healthcare Records Study Br J Gen Pract

Factors that determine patients considering medication for the disease of obesity: an IMI2 SOPHIA study

  • Craig HC, Alsaeed D, Heneghan H, Al-Najim W, Al Ozairi E, le Roux CW. Factors that determine patients considering medication for the disease of obesity: an IMI2 SOPHIA study Int J Obes (Lond)

Duodenal enteroendocrine cells and GIP as treatment targets for obesity and type 2 diabetes

  • Bailey CJ, Flatt PR. Duodenal enteroendocrine cells and GIP as treatment targets for obesity and type 2 diabetes Peptides

Tirzepatide Reduces 24-Hour Ambulatory Blood Pressure in Adults With Body Mass Index ≥27 kg/m(2): SURMOUNT-1 Ambulatory Blood Pressure Monitoring Substudy

  • de Lemos JA, Linetzky B, le Roux CW, Laffin LJ, Vongpatanasin W, Fan L, Hemmingway A, Ahmad NN, Bunck MC, Stefanski A. Tirzepatide Reduces 24-Hour Ambulatory Blood Pressure in Adults With Body Mass Index ≥27 kg/m(2): SURMOUNT-1 Ambulatory Blood Pressure Monitoring Substudy Hypertension

Treatment of obesity with medications binding the glucagon-like peptide 1 receptor: what is the current state of play?

  • Le Roux C, Mondoh A. Treatment of obesity with medications binding the glucagon-like peptide 1 receptor: what is the current state of play? Expert Opin Pharmacother

Continuous Positive Airway Pressure but Not GLP1-mediated Weight Loss Improves Early Cardiovascular Disease in Obstructive Sleep Apnea: A Randomized Proof-of-Concept Study

  • O'Donnell C, Crilly S, O'Mahony A, O'Riordan B, Traynor M, Gitau R, McDonald K, Ledwidge M, O'Shea D, Murphy DJ, Dodd JD, Ryan S. Continuous Positive Airway Pressure but Not GLP1-mediated Weight Loss Improves Early Cardiovascular Disease in Obstructive Sleep Apnea: A Randomized Proof-of-Concept Study Ann Am Thorac Soc

Changes in food preferences and ingestive behaviors after glucagon-like peptide-1 analog treatment: techniques and opportunities

  • Bettadapura S, Dowling K, Jablon K, Al-Humadi AW, le Roux CW. Changes in food preferences and ingestive behaviors after glucagon-like peptide-1 analog treatment: techniques and opportunities Int J Obes (Lond)

Structured lifestyle modification as an adjunct to obesity pharmacotherapy: there is much to learn

  • Murphy E, Finucane FM. Structured lifestyle modification as an adjunct to obesity pharmacotherapy: there is much to learn Int J Obes (Lond)

New therapies for obesity

  • Papamargaritis D, le Roux CW, Holst JJ, Davies MJ. New therapies for obesity Cardiovasc Res

Older posts
Newer posts
← Previous Page1 … Page5 Page6 Page7 … Page23 Next →

Recent Posts

  • 9th ASOI Annual Conference – Registration now open!
  • Press Release for World Obesity Day 4th March 2024
  • ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
  • Things to do in Dublin during ECO
  • ECO 2023 sponsorship update

ASOI

  • info@asoi.info
  • Home
  • ASOI News
  • About Us
  • Events
  • Media Resources
  • Public Resources
  • Guidelines
  • Research
  • Home
  • ASOI News
  • About Us
  • Events
  • Media Resources
  • Public Resources
  • Guidelines
  • Research
  • Privacy Policy
  • Site Map

©2025 ASOI